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In the past decade the genetic contributions to 
cancer syndromes have become clearer[1] and about 
500 familial cancer syndromes have been described 
(a comprehensive list can be found at http://www.
familialcancerdatabase.nl/).[2] Recognition of cancer 
susceptibility in a family can enable individuals at risk to seek 
cancer genetic counselling. The aims of such counselling are to: (i) 
assess family histories in detail; (ii) estimate the risk of developing 
the familial cancer; (iii) provide information so that informed 
decisions about testing, surveillance and prophylactic surgery can 
be made; and (iv) offer support in partnership with attending 
healthcare professionals. [1] This service is available in South Africa 
(SA) to persons who have a family history of cancer and their at-risk 
family members. The Division of Human Genetics, National Health 
Laboratory Service (NHLS), School of Pathology, Faculty of Health 
Sciences, University of the Witwatersrand (Wits), Johannesburg, and 
several other departments of human genetics throughout SA offer 
cancer genetics services.
The first steps in determining whether a hereditary cancer 
syndrome is present in a family are to gather detailed family, medical, 
and lifestyle histories and to obtain details of cancer sites and 
histological features of the tumours.[1] Primary healthcare providers, 
in particular general practitioners (GPs), often have first-level contact 
with patients and are therefore ideally placed to identify individuals 
and families who may be at risk for an inherited cancer syndrome, 
and refer them appropriately to cancer genetic services.[3] Guidelines 
for identifying individuals and/or families at risk for an inherited 
cancer are available, and they are summarised in Table 1.
Studies in the USA[4] and Europe[5] have explored the knowledge 
of primary healthcare physicians, including GPs, regarding cancer 
genetics. The findings showed that they had limited knowledge of 
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Table 1. Medical and family history clues that can indicate 
whether an individual or family is at increased risk for a 
hereditary cancer (after Lalloo et al.[1])
Two or more first- and/or second-degree relatives with the same cancer
Several first- and/or second-degree relatives who have related types of cancer
Two members in the family with the same rare cancer
Two members in the family with related rare cancers
Early age of onset for the specific cancer type (e.g. <50 years for breast cancer)
Bilateral cancer
Multifocal tumours
More than one type of associated cancer in one individual
Specific cancers in high-risk population groups (e.g. Afrikaner or 
Ashkenazi Jewish)
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cancer genetic conditions and services, but other studies showed that 
physicians accepted that they had an increasing role to play in referring 
to such services.[6,7] Since more genetic tests for hereditary cancers are 
becoming available, and public awareness is increasing, the demand 
for cancer genetic services could also increase substantially. [6] GPs as 
well as other healthcare professionals therefore need to understand 
the general principles of cancer genetics[4] so that they are able to 
identify individuals and families at risk and refer them for cancer 
genetic counselling.
Objective
 To investigate, among GPs in Johannesburg, their current knowledge 
regarding three common hereditary cancers (hereditary breast and 
ovarian cancer (HBOC), Lynch syndrome/hereditary non-polyposis 
colorectal cancer (HNPCC) and familial adenomatous polyposis 
(FAP)), their management of patients who could be at risk, and their 
attitudes towards learning more about inherited cancers and the 
relevant services.
Methods
A quantitative, exploratory research design was selected, as it was 
most suitable for the study. The research sample was obtained from 
a list of GPs held by the Department of Family Medicine, School 
of Clinical Medicine, Faculty of Health Sciences, University of the 
Witwatersrand. These GPs were all in private practice and were 
involved in part-time teaching of postgraduate medical students 
pursuing higher degrees or diplomas. Altogether 196 GPs were 
approached (all those listed).
The research tool was a modified structured self-administered 
questionnaire. The original questionnaire was designed by Wideroff 
et al.[4] in the USA and used in this study with Dr Wideroff ’s per-
mission. SA has a unique combination of ethnic groups, and a few 
changes were made to the questionnaire to make it suitable for the 
local situation. 
The questionnaire was tested in a pilot study on five subjects 
(private GPs in a multipractice setting in Johannesburg) and minor 
amendments were made. A research recruitment package was then 
compiled and posted to the 196 listed GPs. The package contained an 
information sheet describing the study, the questionnaire, a consent 
sheet, and separate self-addressed envelopes (one for the completed 
questionnaire and the other for the response sheet, in order to ensure 
the anonymity of the GPs) and a covering letter.
The GPs were given 4 weeks to complete and return both 
the questionnaire and the consent sheet, after which a follow-
up recruitment package was sent to non-responders. Seventy 
questionnaires were returned, including 61 completed questionnaires 
(round 1 = 26, round 2 = 35), one blank, and eight returned by 
the post office owing to incorrect addresses or for other unknown 
reasons. Data were collected between March and August 2005.
The responses from the completed questionnaires were entered 
into an Excel database and analysed using descriptive statistics and 
t-tests. Ethical approval for the study was provided by the Human 
Research Ethics Committee (Medical), Faculty of Health Sciences, 
University of the Witwatersrand (reference number M070219, 
7 March 2005).
Results
The sample
A total of 61/196 GPs completed and returned the questionnaire, 
giving a final response rate of 31.1%. A review of published research 
with a focus on mail survey research concluded that response rates 
can vary from 2.5% to 97.7%, depending on the study.[8] According 
to Neuman,[9] a response rate of 31% is considered reasonable for a 
postal survey. The sample of GPs was affiliated with the University 
of the Witwatersrand and may have been relatively more inclined/
willing to participate in the research project. The demographic details 
of the respondents are given in Table 2. The GPs estimated that they 
saw an average of 110 patients (more females (60/110, 54.5%) than 
males (50/110, 45.5%)) a week, and they worked on average 45 hours 
per week (range 7 - 72 hours). Forty-five (45/67, 67.2%) of the GPs 
had a limited family history of cancer themselves. About half of 
them (32/61, 52.5%) reported that they worked in a multiple practice 
setting with between 2 and 10 partners.
Family history information, risk assessment  
management and referral
The GPs stated that they gathered some medical and cancer history 
on new patients (Fig. 1). Significantly more GPs collected informa-
tion on their patients (100.0%) and on the patients’ first-degree 
relatives (93.4%) than on their second-degree relatives (73.8%; 
p<0.001) or ages at cancer diagnosis (72.1%; p<0.001). However, the 
GPs were found to make use of several cancer screening procedures 
including mammography (98.4%), clinical breast examination 
(95.1%), prostate-specific antigen measurement (91.8%), Pap smears 
(86.9%), faecal occult blood tests (67%), abdominal ultrasound 
(60.7%) and CA-125 marker tests (57.4%).
About half (34/61, 55.7%) of the respondents stated that some 
of their patients enquired about the possibility of an increased 
cancer risk. Overall, 24.6% (15/61) reported that they assessed 
their patients’ risk of having a hereditary cancer; however, they 
were not asked to describe how they assessed these risks. The 
Table 2. Demographic characteristics of the respondents (N= 61)
n (%)
Age (years)
30 - 39 14 (23.0)
40 - 49 22 (36.1)
50 - 59 11 (18.0)
60 - 69 14 (23.0)
Primary qualification Bachelor of Medicine and Surgery 61 (100.0)
In addition to Bachelor of Medicine and Surgery
Degrees: BSc, BSc Hons, BPharm 8 (13.1)
Diplomas: DA, DCH 21 (34.4)
Average number of patients seen per week 110
Average hours per week spent in practice 45
Re
sp
on
se
s,
 %
Medical and cancer history taken
120.0
100.0
80.0
60.0
40.0
20.0
0.0
Patient FDR SDR Age of CA
diagnosis
Yes
No
100.0
0.0
93.4
6.6
73.8
26.2
72.1
27.9
Fig. 1. Information collected from patients regarding cancer in the family. 
(FDR = first-degree relatives; SDR = second-degree relatives; CA = cancer.)
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remainder (75.4%, 46/61) were unsure how to perform such risk 
assessments. Twenty-two GPs (36.1%) referred patients for cancer 
genetic counselling. Of this group, 54.5% (12/22) referred patients 
to the Clinical and Counselling Section in the Division of Human 
Genetics, NHLS/Wits, while 45.5% (10/22) referred patients to 
other facilities that do not have trained genetic counsellors and 
medical geneticists.
Knowledge about genes and genetic testing for cancer
When asked about available testing, more participants knew about 
the tests for breast cancer than about those available for colon cancer 
(Table 3). About a third (18/61) of GPs correctly responded that 
<10% of females with breast and ovarian cancer are at risk of carrying 
a known BRCA1/2 gene mutation. Only 27/61 (44.3%) knew that 
a breast cancer mutation can be inherited from the paternal side. 
Further, only 4.9% (3/61) correctly responded to a question about the 
penetrance of HNPCC mutations (i.e. that penetrance is about ≥50%). 
Most of the GPs (57/61, 83.4%) thought that patients should have 
genetic counselling before having genetic testing, while many (39/61, 
63.9%) expected that the numbers of patients undergoing cancer 
genetic testing would increase in the future and that they would be 
involved in the testing process.
All the GPs (61/61, 100%) agreed that a genetic counsellor is the 
most qualified professional to provide genetic counselling to patients, 
followed by a medical geneticist (52/61, 85.2%) and an oncologist 
(42/61, 68.9%). Most (40/61, 65.6%) believed that they themselves 
were not sufficiently qualified and equipped to provide genetic 
counselling for hereditary cancers.
Attitudes regarding continuing medical education  
in cancer genetics
Most GPs (57/61, 93.4%) who participated in this study believed 
that genetic counselling should be offered prior to testing. 
Furthermore they reported being interested in learning more 
about hereditary cancers and becoming more involved in referring 
at-risk patients appropriately (53/61, 86.9%). The majority (60/61, 
98.4%) of GPs believed that there was a need for guidelines on 
cancer genetics. They felt that continuing medical education 
sessions (53/61, 86.9%), discussions with their colleagues (50/61, 
82.0%), guidelines from government, societies and agencies (50/61, 
82.0%) and data published in scientific journals (54/61, 88.5%) 
were important resources from which they could learn more about 
cancer genetics.
Discussion
This is the first published study exploring the practice, knowledge 
and attitudes of GPs in SA regarding their knowledge of hereditary 
cancer and genetic counselling and testing. Although this was a 
small study, the knowledge and attitudes of the cohort were similar 
to those reported from similar surveys of GPs and specialists in 
other parts of the world.[4-7] A study by Nippert et al.[10] showed that 
confidence on the part of participating physicians in their ability to 
carry out basic medical genetics tasks was low.
The key to identifying individuals at risk for an inherited cancer 
is to assess their family history carefully,[1] so that responses can 
be provided to the items presented in Table 1. The results of the 
present study showed that 26.2% (16/61) of the GPs did not collect 
a sufficiently comprehensive family history, which should include 
second-degree family members and the age of cancer onset in 
affected individuals. Partial family history information would limit a 
GP’s ability to assess the risks for an inherited cancer susceptibility. 
These findings support those reported in two studies in the USA on 
taking, interpreting and assessing cancer family history by family 
physicians.[11,12] These studies further found that family physicians 
lack confidence and available time to assess and communicate 
hereditary cancer risks. In the current study, 75.4% of GPs were 
not certain of how to assess their patients’ risks for a hereditary 
cancer and few (36.1%) referred patients to appropriate cancer 
genetic services. This finding suggests that GPs are not equipped 
with the correct knowledge and tools to assess their patients’ risks 
for hereditary cancers, and many are unaware of the available 
cancer genetic services. A suggested solution could be to create 
appropriate risk assessment and referral guidelines similar to those 
of the National Institute for Health and Care Excellence (NICE) in 
the UK[13] for use in the SA situation. These guidelines should enable 
healthcare professionals to identify patients at risk and refer them 
appropriately for more advanced risk assessment, cancer genetic 
counselling and possibly genetic testing.
An assessment of the GPs’ knowledge about key cancer genetic 
concepts and genetic testing for HBOC, HNPCC and FAP showed an 
overall better understanding of HBOC. A possible explanation is that 
HBOC is more common and has probably had more media coverage 
than other cancer syndromes.[14] About a third of the GPs understood 
that 5 - 10% of breast and/or ovarian cancers are inherited, and 
44.3% knew that the BRCA genes causing HBOC can be inherited 
from the paternal line. These findings were very similar to those 
reported by Wideroff et al.,[4] who investigated HBOC, HNPCC 
and FAP genetic knowledge in a national sample of US physicians. 
The penetrance of HNPCC genes is ≥50% (i.e. only about half the 
individuals who carry the gene will show signs and symptoms). In 
the present study only 5% of GPs understood this fact correctly, 
compared with 13% reported by Wideroff et al.[4] Also, at the time 
we did our study, diagnostic testing for HBOC was available, whereas 
genetic testing for HNPCC and FAP is mostly only available on a 
research basis. Diagnostic testing, when necessary, was at the time of 
the study referred to reputable laboratories overseas. However, even 
in the absence of genetic testing individuals can benefit from genetic 
counselling, so that they understand their risks and make informed 
choices about management and future options.
It is strongly recommended that patients have genetic counselling 
prior to any genetic testing. A genetic counsellor can assess risks, 
empower the counselee with information regarding the testing 
procedures, discuss the advantages and limitations of the tests, and 
promote informed choices, as well as provide empathic emotional 
support throughout the whole process.[15] A very positive finding was 
that the GPs understood this recommendation, and 93.4% (57/61) 
agreed that patients should have genetic counselling prior to genetic 
testing.
Fry et al.[6] found that many GPs in Edinburgh, UK, did not feel 
equipped to counsel patients about cancer risks. These findings 
support those reported in the current study, where 65.6% of GPs 
reported that they did not feel qualified or equipped to provide 
cancer genetic counselling for hereditary cancers. Another study 
Table 3. GPs’ (N=61) knowledge about genetic testing services 
for specific cancer genes associated with three of the most 
common inherited cancer syndromes
Inherited cancer  
syndrome Associated genes
Testing available,
n (%)
HBOC BRCA1 and BRCA2 28 (45.9)
Lynch syndrome/HNPCC hMSH2 and hMLH1 8 (13.1)
FAP APC 9 (14.8)
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in the USA investigated possible reasons why GPs did not want 
to counsel patients about inherited cancers, and attributed their 
reluctance to time constraints.[4] However, a study by Watson 
et al.[7] has shown that GPs are prepared to be gatekeepers and 
participate in family history taking, deciding which patients to 
refer for genetic counselling and testing, and managing at-risk 
patients with a predisposition to cancer. In the current study, GPs 
showed interest in being more involved in providing cancer genetic 
services and 86.9% (53/61) wanted to learn more about specific 
areas of inherited cancer and the available genetic services. There is 
therefore a need for continuing medical education, the development 
of specific guidelines in the field, and articles in scientific journals. 
Such an awareness programme, which includes the distribution 
of information booklets, cancer genetics pamphlets, educational 
lectures and workshops, has already been initiated.
Conclusions
The findings from this study showed GPs have limited knowledge 
about basic concepts of hereditary cancers and available local genetic 
counselling and testing services. As a result, at-risk patients and 
their families may not be identified or referred for specialist care and 
management. Fortunately, however, GPs are interested in learning 
more about hereditary cancers and in becoming more involved in 
referring at-risk patients appropriately.
It has been suggested that public awareness about the rapid 
advances in cancer genetics and inherited cancer syndromes would 
increase the demand for cancer genetic services and testing.[16] 
Within the past 10 years the numbers of breast, ovarian and colorectal 
cancer cases seen in the Division of Human Genetics in Johannesburg 
has increased rapidly. This demand is expected to increase even more 
in the future, as has occurred in other human genetics departments 
such as the Queensland Clinical Genetics Service in Australia. [17] 
It is therefore necessary to meet the educational needs of GPs 
by putting together and circulating informational documents and 
pamphlets about the common hereditary cancers, as well as referral 
guidelines. The NICE guidelines[13] were developed to address 
primary, secondary and tertiary healthcare professionals and to 
guide them in classifying and caring for women at risk of breast 
cancer. Further research involving SA’s unique population and the 
local healthcare system could enable the development of a similar 
document, which should be a quick and easy guide for all healthcare 
professionals. HBOC in black African patients is currently poorly 
understood, but local patient samples have been studied in an MSc 
dissertation and guidelines for identifying at-risk patients have been 
recommended.[18]
As an outcome of the present study, the professional staff of the 
Division of Human Genetics, NHLS/Wits are attempting to meet 
some of GPs’ educational needs. Pamphlets have been distributed, 
advertising services provided and workshops and talks on cancer 
genetics held. At the same time, medical students are receiving 
training, in this field, which should be of benefit in future to families 
with a hereditary cancer syndrome.
Acknowledgements. We thank the GPs who participated in this study, 
the staff of the Department of Family Medicine of the University of the 
Witwatersrand, Prof. Bruce Sparks for assisting with the sample selection, 
Dr L Wideroff from the National Cancer Institute, Bethesda, USA, for 
permission to adapt and use her questionnaire, the Division of Human 
Genetics, NHLS/Wits for funding for the project, and Prof. Marion 
McAllister, University of Cardiff, Wales, for final editorial advice.
References
1. Lalloo F, Kerr B, Friedman JM, Evans DGR. Risk Assessment and Management in Cancer Genetics. 
New York: Oxford University Press, 2006:3-12.
2. Familial Cancer Database Online. Familial cancer syndromes. 2011. http://www.familialcancerdatabase.
nl/ (accessed 26 July 2015).
3. McKelvey KD Jr, Evans JP. Cancer genetics in primary care. J Nutr 2003;133(11 Suppl 1):3767S-3772S.
4. Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN. Hereditary breast/
ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet 
2005;42(10):749-755. [http://dx.doi.org/10.1136/jmg.2004.030296]
5. Escher M, Sappino AP. Primary physicians’ knowledge and attitudes towards genetic testing for breast-
ovarian cancer predisposition. Ann Oncol 2000;11(9):1131-1135.
6. Fry A, Campbell H, Gudmunsdottir H, et al. GPs’ views on their role in cancer genetics services and 
current practice. Fam Pract 1999;16(5):468-474. [http://dx.doi.org/10.1093/fampra/16.5.468]
7. Watson EK, Shickle D, Qureshi N, Emery J, Austoker J. The ‘new genetics’ and primary care: GPs’ views 
on their role and their educational needs. Fam Pract 1999;16(4):420-425. [http://dx.doi.org/10.1093/
fampra/16.4.420]
8. Larson PD. A note on mail surveys and response rates in logistics research. Journal of Business 
Logistics 2005;26(2):211-222. [http://dx.doi.org/10.1002/j.2158-1592.2005.tb00212.x]
9. Neuman WL. Social Research Methods: Qualitative and Quantitative Approaches. 7th ed. Boston: 
Allyn & Bacon, 2009:640.
10. Nippert I, Harris HJ, Julian-Reynier C, et al. Confidence of primary care physicians in their ability 
to carry out basic medical genetic tasks – a European survey in five countries – Part 1. J Community 
Genet 2011;2(1):1-11. [http://dx.doi.org/10.1007/s 12687-010-0030-0]
11. Tyler CV, Snyder CW. Cancer risk assessment: Examining the family physician’s role. J Am Board Fam 
Med 2006;19(5):468-477. [http://dx.doi.org/10.3122/jabfm.19.5.468] 
12. Wood ME, Stockdale A, Flynn BS. Interviews with primary care physicians regarding taking and 
interpreting the cancer family history. Fam Pract 2008;25(5):334-340. [http://dx.doi.org/10.1093/
fampra/cmn053]
13. National Institute for Health and Care Excellence (NICE). 2013. http://www.nice.org.uk/ (accessed 
27 September 2013). 
14. Gerlach KK, Marino C, Hoffman-Goetz L. Cancer coverage in women’s magazines: What 
information are women receiving? J Cancer Educ 1997;12(4):240-244. PMID: 9440017. [http://dx.doi.
org/10.1080/08858199709528496]
15. Resta R, Biesecker BB, Bennett RL, et al. New Definition of Genetic Counseling: National Society of 
Genetic Counsellors’ Task Force Report. J Genet Couns 2006;15(2):77-83. [http://dx.doi.org/10.1007/
s10897-005-9014-3]
16. Bathurst L, Huang QR. A qualitative study of GPs’ views on modern genetics. Aust Fam Physician 
2006;35(6):462-464. 
17. Kromberg JGR, Parkes J, Taylor S. Genetic counselling as a developing healthcare profession: A case 
study in the Queensland context. Aust J Prim Health 2005;12(1):33-39. [http://dx.doi.org/10.1071/
PY06006]
18. Wainstein T. Family history and risk assessment in black South African women with breast cancer. 
MSc (Med) dissertation. Johannesburg: University of the Witwatersrand, 2011:70. http://wiredspace.
wits.ac.za/bitstream/handle/10539/11052/0611283G_TASHA%20WAINSTEIN_RESEARCH%20
REPORT_CORRECTED_FINAL_11%20.pdf?sequence=1 (accessed 1 October 2015).
Accepted 5 October 2015.
